Paradigm Biopharmaceuticals Ltd
PAR•Health Care•Biotechnology•Last updated: Dec 25
About
Paradigm Biopharmaceuticals Ltd is a biotechnology company focused on the research and development of therapeutic products for the treatment of inflammation-related diseases. The company is primarily engaged in repurposing the drug pentosan polysulfate sodium (PPS) for new orthopaedic and respiratory applications. Paradigm's main segments include the development of treatments for osteoarthritis and other musculoskeletal disorders.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- PAR
Related Shares
Investor Resources
Should you buy Paradigm Biopharmaceuticals Ltd right now?
While PAR looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now